Terms: = Uterine cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
82 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.
Evans I; Reisel D; Jones A; Bajrami A; Nijjar S; Solangon SA; Arora R; Redl E; Schreiberhuber L; Ishaq-Parveen I; Rothärmel J; Herzog C; Jurkovic D; Widschwendter M
Lancet Oncol; 2023 Dec; 24(12):1375-1386. PubMed ID: 37944542
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer.
Pelegrina B; Paytubi S; Marin F; Martínez JM; Carmona Á; Frias-Gomez J; Peremiquel-Trillas P; Dorca E; Zanca A; López-Querol M; Onieva I; Benavente Y; Barahona M; Fernandez-Gonzalez S; De Francisco J; Caño V; Vidal A; Pijuan L; Canet-Hermida J; Dueñas N; Brunet J; Pineda M; Matias-Guiu X; Ponce J; Bosch FX; De Sanjosé S; Alemany L; Costas L
EBioMedicine; 2023 Aug; 94():104716. PubMed ID: 37480623
[TBL] [Abstract] [Full Text] [Related]
4. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
5. uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
Fasciani A; Turtulici G; Pedullà A; Sirito R
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
[TBL] [Abstract] [Full Text] [Related]
6. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome of photodynamic therapy for the treatment of cervical intraepithelial neoplasia grade 2.
Cai H; Che Y; Sun X; Yu X; Yu F; Hou F; Wang Y; Ma T
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102906. PubMed ID: 35577063
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
Gauci PA; Kee DLC; Thamphya B; Schiappa R; Delotte J; Chand-Fouche ME; Hannoun-Levi JM
Brachytherapy; 2022; 21(3):273-282. PubMed ID: 35094933
[TBL] [Abstract] [Full Text] [Related]
10. A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma.
Devereaux KA; Steiner DF; Ho C; Gomez AJ; Gilks B; Longacre TA; Zehnder JL; Howitt BE; Suarez CJ
Int J Gynecol Pathol; 2022 Nov; 41(6):541-551. PubMed ID: 34907997
[TBL] [Abstract] [Full Text] [Related]
11. clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
[TBL] [Abstract] [Full Text] [Related]
12. Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations.
Qiu Q; Zhou Q; Luo A; Li X; Li K; Li W; Yu M; Amanullah M; Lu B; Lu W; Liu P; Lu Y
Genomics; 2021 May; 113(3):1554-1564. PubMed ID: 33785400
[TBL] [Abstract] [Full Text] [Related]
13. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
[TBL] [Abstract] [Full Text] [Related]
14. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract] [Full Text] [Related]
15. Association Between Radiation Tolerance of Lymphocytes and clinical outcomes in Cervical cancer.
Lee S; Cho O; Chun M; Chang SJ; Kong TW; Lee EJ; Lee Y
In Vivo; 2019; 33(6):2191-2198. PubMed ID: 31662555
[TBL] [Abstract] [Full Text] [Related]
16. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: clinical feasibility and outcome.
Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
[TBL] [Abstract] [Full Text] [Related]
17. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract] [Full Text] [Related]
18. Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention.
Yoon JK; Han K; Kim MD; Kim GM; Kwon JH; Won JY; Lee DY
Eur J Radiol; 2018 Dec; 109():83-87. PubMed ID: 30527317
[TBL] [Abstract] [Full Text] [Related]
19. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract] [Full Text] [Related]
20. clinical outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only.
Smogeli E; Cvancarova M; Wang Y; Davidson B; Kristensen G; Lindemann K
Int J Gynecol Cancer; 2018 Nov; 28(9):1789-1795. PubMed ID: 30365455
[TBL] [Abstract] [Full Text] [Related]
[Next]
